The present invention relates to estrogen receptor ligands, and compounds and methods for treating diseases associated with excessive estrogen receptor activity. Compound of the formula I are disclosed: ##STR00001## wherein W is O or (CR.sub.8).sub.2, and R.sub.1 to R.sub.8, Y, and m are defined as defined herein.